Gene therapy for barrett's esophagus: Adenoviral gene transfer in different intestinal models

Cancer Gene Therapy

Volumn 12, Issue 9, 2005, Pages 778-786

  Marsman, Willem A ^a   Buskens, Christianne J ^a   Wesseling, John G ^a   Van Lanschot, J Jan B ^a   Bosma, Piter J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Adenovirus; Barrett's esophagus; Differentiation; Esophageal cancer; Gene therapy; RGD

Indexed keywords

ACETYLCYSTEINE; ADENOVIRUS VECTOR; ARGINYLGLYCYLASPARTIC ACID; DIETHYLAMINOETHYLDEXTRAN; GREEN FLUORESCENT PROTEIN; MUCOLYTIC AGENT; POLYCATION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BARRETT ESOPHAGUS; CELL DIFFERENTIATION; CELL STRAIN CACO 2; CONTROLLED STUDY; DISEASE MODEL; ESOPHAGOJEJUNOSTOMY; ESOPHAGUS TUMOR; FEASIBILITY STUDY; GENE TARGETING; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ACETYLCYSTEINE; ADENOVIRIDAE; ANIMALS; BARRETT ESOPHAGUS; CACO-2 CELLS; DEAE-DEXTRAN; DISEASE MODELS, ANIMAL; GENE THERAPY; GREEN FLUORESCENT PROTEINS; HUMANS; INTESTINES; RATS; TRANSDUCTION, GENETIC;

ADENOVIRIDAE;

EID: 23944500837     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700841     Document Type: Article

References (32)

1. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med. 1985;313:857-859.
2. Devesa SS, Blot WJ, Fraumeni Jr JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049-2053.
3. Sharma P. An update on strategies for eradication of Barrett's mucosa. Am J Med. 2001;111(Suppl 8A):147S-152S.
4. Schmid RM, Weidenbach H, Draenert GF, et al. Liposome mediated gene transfer into the rat oesophagus. Gut. 1997;41:549-556.
5. Hidalgo IJ, Raub TJ, Borchardt RT. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology. 1989;96:736-749.
6. Meunier V, Bourrie M, Berger Y, et al. The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications. Cell Biol Toxicol. 1995;11:187-194.
7. Hulscher JB, Buskens CJ, Huyzer G, et al. An animal model for Barrett's oesophagus but not for Barrett's cancer. Thesis, University of Amsterdam. 2004.
8. Bergelson JM, Cunningham JA, Droguett G, et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 1997;275:1320-1323.
9. Krasnykh V, Dmitriev I, Mikheeva G, et al. Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J Virol. 1998;72:1844-1852.
10. Dmitriev I, Krasnykh V, Miller CR, et al. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol. 1998;72:9706-97I3.
11. Graham FL, Prevec L. Methods for construction of adenovirus vectors. Mol Biotechnol. 1995;3:207-220.
12. Marsman WA, Buskens CJ, Wesseling JG, et al. Gene therapy for esophageal carcinoma: the use of an explant model to test adenoviral vectors ex vivo. Cancer Gene Ther. 2004;11:289-296.
13. Westbrook CA, Chmura SJ, Arenas RB, et al. Human APC gene expression in rodent colonic epithelium in vivo using liposomal gene delivery. Hum Mol Genet. 1994;3:2005-2010.
14. Schmid RM, Weidenbach H, Draenert GF, et al. Liposome mediated in vivo gene transfer into different tissues of the gastrointestinal tract. Z Gastroenterol. 1994;32:665-670.
15. Cheng DY, Kolls JK, Lei D, et al. In vivo and in vitro gene transfer and expression in rat intestinal epithelial cells by E1-deleted adenoviral vector. Hum Gene Ther. 1997;8:755-764.
16. Foreman PK, Wainwright MJ, Alicke B, et al. Adenovirus-mediated transduction of intestinal cells in vivo. Hum Gene Ther. 1998;9:1313-1321.
17. Walter E. Adenovirus mediated gene transfer to intestinal epithelial cells as a potential approach for oral delivery of peptides and proteins. J Controlled Rel. 1997;46:75-87.
18. Lojda Z. Indigogenic methods for glycosidases. II. An improved method for beta-D-galactosidase and its application to localization studies of the enzymes in the intestine and in other tissues. Histochemie. 1970;23:266-288.
19. Croyle MA, Stone M, Amidon GL, et al. In vitro and in vivo assessment of adenovirus 41 as a vector for gene delivery to the intestine. Gene Therapy. 1998;5:645-654.
20. Cheng X, Ming X, Croyle MA. PEGylated adenoviruses for gene delivery to the intestinal epithelium by the oral route. Pharm Res. 2003;20:1444-1451.
21. Croyle MA, Roessler BJ, Hsu CP, et al. Beta cyclodextrins enhance adenoviral-mediated gene delivery to the intestine. Pharm Res. 1998;15:1348-1355.
22. Liptay S, Weidenbach H, Adler G, et al. Colon epithelium can be transiently transfected with liposomes, calcium phosphate precipitation and DEAE dextran in vivo. Digestion. 1998;59:142-147.
23. Kaplan JM, Pennington SE, St George JA, et al. Potentiation of gene transfer to the mouse lung by complexes of adenovirus vector and polycations improves therapeutic potential. Hum Gene Ther. 1998;9:1469-1479.
24. Fasbender A, Zabner J, Chillon M, et al. Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo. J Biol Chem. 1997;272:6479-6489.
25. Ferrari S, Kitson C, Parley R, et al. Mucus altering agents as adjuncts for nonviral gene transfer to airway epithelium. Gene Therapy. 2001;8:1380-1386.
26. Kitson C, Angel B, Judd D, et al. The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium. Gene Therapy. 1999;6:534-546.
27. Sandberg JW, Lau C, Jacomino M, et al. Improving access to intestinal stem cells as a step toward intestinal gene transfer. Hum Gene Ther. 1994;5:323-329.
28. Cryan SA, O'Driscoll CM. Mechanistic studies on nonviral gene delivery to the intestine using in vitro differentiated cell culture models and an in vivo rat intestinal loop. Pharm Res. 2003;20:569-575.
29. Greber UF. Virus assembly and disassembly: the adenovirus cysteine protease as a trigger factor. Rev Med Virol. 1998;8:213-222.
30. Jornot L, Morris MA, Petersen H, et al. N-acetylcysteine augments adenovirus-mediated gene expression in human endothelial cells by enhancing transgene transcription and virus entry. J Gene Med. 2002;4:54-65.
31. Cohen CJ, Shieh JTC, Pickles RJ, et al. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. PNAS. 2001;98:15191-15196.
32. Beaulieu JF. Extracellular matrix components and integrins in relationship to human intestinal epithelial cell differentiation. Prog Histochem Cytochem. 1997;31:1-78.